Carcinogens and Genotoxicity Assessment
Research Guide

The Comet Assay is a technique for quantitation of low levels of DNA damage in individual cells, developed by Singh et al. (1988) in 'A simple technique for quantitation of low levels of DNA damage in individual cells'. It visualizes DNA strand breaks as comet-shaped tails under electrophoresis. Guidelines for its use in genetic toxicology testing were established by Tice et al. (2000) in 'Single cell gel/comet assay: Guidelines for in vitro and in vivo genetic toxicology testing'.

The Ames test uses Salmonella strains to detect carcinogens and mutagens via the salmonella/mammalian-microsome mutagenicity test, as introduced by Ames et al. (1975) in 'Methods for detecting carcinogens and mutagens with the salmonella/mammalian-microsome mutagenicity test'. It measures reversion mutations induced by test chemicals with metabolic activation. Revised methods were published by Maron and Ames (1983) in 'Revised methods for the Salmonella mutagenicity test'.

DNA damage response pathways underpin human disease including cancer, as detailed by Jackson and Bártek (2009) in 'The DNA-damage response in human biology and disease'. Instability and decay of DNA's primary structure contribute to mutations, per Lindahl (1993) in 'Instability and decay of the primary structure of DNA'. Programmed cell death via nuclear DNA fragmentation links to carcinogenesis, shown by Gavrieli et al. (1992).

Standard methods include the Comet Assay, Micronucleus Assay, and Ames test for detecting DNA damage, mutations, and carcinogens. Tice et al. (2000) provide guidelines for Comet Assay application in genetic toxicology. Ames tests detect environmental mutagens, per Ames et al. (1975) and Maron and Ames (1983).

A simple salting out procedure extracts DNA from human nucleated cells, described by Miller et al. (1988) in 'A simple salting out procedure for extracting DNA from human nucleated cells'. This method supports downstream assays like PCR and genotoxicity analysis. It is widely used due to its simplicity and effectiveness.

IARC Monographs evaluate carcinogenic risks to humans, as in Zuckerman (1995) 'IARC Monographs on the Evaluation of Carcinogenic Risks to Humans', addressing agents like viral hepatitis causing morbidity and mortality. They classify carcinogens for regulatory use. These evaluations guide global public health policies.